Use and Costs of Instrument-Based Vision Screening for US Children Aged 12 to 36 Months

JAMA Pediatr. 2023 Jul 1;177(7):728-730. doi: 10.1001/jamapediatrics.2023.0808.

Authors

Isdin Oke¹, Sharon M Lutz², David G Hunter¹, Alison A Galbraith^{2

3}

Affiliations

¹ Department of Ophthalmology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.
² Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
³ Now with Department of Pediatrics, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Massachusetts.

PMID: 37213124
PMCID: PMC10203963 (available on 2024-05-22)
DOI: 10.1001/jamapediatrics.2023.0808

No abstract available

Plain language summary

This cohort study examines patterns and out-of-pocket costs of instrument-based screening among children 12 to 36 months.

Publication types

Research Support, U.S. Gov't, P.H.S.

MeSH terms

Child
Health Care Costs
Health Expenditures
Humans
Vision Screening*

Grants and funding

T32 HS000063/HS/AHRQ HHS/United States